The association of conjugated bile acids (CBAs) and S1PR2 alterations with the onset of NASH hepatocarcinogenesis was found in human NAFLD/NASH-HCCs in vivo and in Huh 7 and HepG2 hepatoma cell lines [26]. This evidence concerns the gene S1PR2 and metabolic dysfunction-associated steatotic liver disease.